Health BridgeBio Pharma shares rise on ‘compelling’ Phase 3 trial results for achondroplasia drug By Proactive 12/02
Health Inside Biotech: Healthscope’s long, troubled journey to a not-for-profit rescue By Proactive 09/02
Health Rhythm Biosciences locks in commercial manufacturing partner for ColoSTAT rollout By Proactive 03/02
Health Solvonis Therapeutics expands scope of SVN-015 to potentially include depression treatment By Proactive 28/01
Health ImmunityBio shares rise on positive CAR-NK trial results in Waldenström lymphoma By Proactive 16/01
Health Inside Biotech: Eikon Therapeutics joins IPO queue with late-stage oncology focus By Proactive 13/01
Health HaemaLogiX names Dr Chris Baldwin CEO and managing director as it eyes 2026 IPO By Proactive 13/01
Health Solvonis Therapeutics adds patent protection for its post-traumatic stress disorder programme By Proactive 07/01
Health Rezolute shares plunge on disappointing Phase 3 congenital hyperinsulinism trial results By Proactive 11/12/2025
Health Inside Biotech: Epiminder’s IPO tests investor appetite for med-tech scale-up stories By Proactive 10/12/2025
Health Acadia Healthcare downgraded on rising legal and insurance costs, shares drop By Proactive 03/12/2025
